Acetaminophen Use with Elevated Liver Enzymes

Understanding the Risk

Elevated transaminases indicate significant existing liver injury, and acetaminophen is primarily metabolized by the liver, according to the American Association for the Study of Liver Diseases 1, 2

These enzyme levels suggest active hepatocellular injury that could be exacerbated by introducing acetaminophen, as reported by the American Association for the Study of Liver Diseases 3, 4

For patients with liver disease requiring pain management, the American Association for the Study of Liver Diseases recommends consulting with a specialist for appropriate analgesic selection, using opioids with careful dose adjustment, and avoiding NSAIDs 5, 6

If pain management is absolutely necessary, and after liver injury etiology is determined, acetaminophen might be reconsidered at reduced dosing only after transaminases have significantly improved, as suggested by the American Association for the Study of Liver Diseases 5, 6
In patients with acetaminophen-induced liver injury, N-acetylcysteine therapy should be initiated promptly, according to the American Society of Anesthesiologists 7
For patients with acute liver failure of any etiology, consultation with a liver transplant center is recommended, as advised by the American Society of Anesthesiologists 7